J. Rosecke, W.A. Konig / Phytochemistry 54 (2000) 757±762
È È
761
29), 1.05 (3H, s, H-18), 1.13 (3H, s, H-19), 1.14 (3H, s,
H-28), 1.46 (3H, s, H-30), 4.53 (1H, dd, J 7:6, 6:6
Hz, H-16), 4.85 (1H, s, H-31a), 4.98 (1H, s, H-31b).
13C-NMR (100.61 MHz, pyridine-d5): see Table 1.
(8), 467 [M
(13), 325 (87), 151 (100), 69 (94).
Me]+ (23), 449 [M
Me
H2O]+
3.18. Compound 8, quercinic acid C, 3b,12b-dihydroxy-
24-methyl-23-oxolanost-8-en-26-oic acid
3.13. Compound 3, 16-O-acetylpolyporenic acid C, 16a-
acetoxy-24-methylene-3-oxolanosta-7,9(11)-dien-21-oic
acid
Amorphous light brown solid, a20 86:0 (CH2Cl2,
c0.05). 1H-NMR (400.13 MHz, pyridine-d5): d 0.92
(3H, s, H-28), 0.94 (3H, s, H-30), 1.05 (3H, s, H-18),
1.08 (3H, s, H-19), 1.15 (3H, d, J 6:9 Hz, H-31),
1.23 (3H, s, H-29), 1.34 (3H, d, J 7:2 Hz, H-27),
1.35 (3H, d, J 7:3 Hz, H-21), 2.57 (1H, dd, J 17:3,
10.1 Hz, H-20), 2.86 (1H, dd, J 17:6, 6.9 Hz, H-22a),
3.17 (2H, m, H-24, H-25), 3.63 (1H, br. s, H-3), 4.39
(1H, t, J 7:9 Hz, H-12). 13C-NMR (100.61 MHz,
pyridine-d5): see Table 1. EI-MS m/z (rel. int.): 502
Obtained only as a mixture with 4. 13C-NMR
(100.61 MHz, CDCl3): see Table 1.
3.14. Compound 4, 16a-acetoxy-24-methylene-3-
oxolanost-8-en-21-oic acid
Obtained only as a mixture with 3. 13C-NMR
(100.61 MHz, CDCl3): see Table 1.
[M]+ (7), 484 [M
Me]+ (100), 451 [M
309 (31), 69 (74).
H2O]+ (11), 469 [M
2 H2O
Me]+ (47), 325 (38),
H2O
3.15. Compound 5, 3a-carboxyacetoxyquercinic acid,
3a-carboxyacetoxy-24-methyl-23-oxolanost-8-en-26-oic
acid
3.19. Compound 9, 3a-oxepanoquercinic acid C, 12b,23-
epoxy-3a,23-dihydroxy-24-methyllanost-8-en-26-oic acid
1H-NMR (400.13 MHz, CDCl3): d 0.74 (3H, s, H-
18), 0.87 (3H, d, J 7:6 Hz, H-21), 0.89 (3H, s, H-29),
0.93 (3H, s, H-30), 0.94 (3H, s, H-28), 1.00 (3H, s, H-
19), 1.09 (3H, d, J 7:1 Hz, H-31), 1.21 (3H, d, J
6:9 Hz, H-27), 3.45 (2H, s, H-2'), 4.76 (1H, br. s, H-3).
13C-NMR (100.61 MHz, CDCl3): see Table 1. EI-MS
Amorphous white solid. 1H-NMR (400.13 MHz,
CDCl3): d 0.76 (3H, s, H-18), 0.84 (3H, s, H-29), 0.89
(3H, s, H-28), 0.98 (3H, d, J 8:2 Hz, H-21), 0.99
(3H, s, H-19), 0.99 (3H, s, H-30), 1.10 (3H, d, J 6:7
Hz, H-31), 1.24 (3H, d, J = 7.1 Hz, H-27), 2.65 (1H,
m, H-17), 4.34 (1H, t, J 8:1 Hz, H-12), 4.74 (1H, br.
s, H-3). 13C-NMR (100.61 MHz, CDCl3): see Table 1.
m/z (rel. int.): 528 [M
CO2]+ (9), 513 [M
CO2
Me]+ (13), 453 (80), 435 (21), 309 (52), 153 (71), 43
(100).
3.16. Compound 6, ergosterol peroxide, 5a,8a-
epidioxyergosta-6,22-dien-3b-ol
3.20. Compound 10, methyl (E )-4-methoxycinnamate
Obtained only as a mixture with 11. 1H-NMR
(400.13 MHz, CDCl3): d 3.80 (3H, s, OMe), 3.85 (3H,
s, COOMe), 6.32 (1H, d, J 16:2 Hz, H-8), 6.92 (2H,
dt, J 9:1, 1.6 Hz, H-3, H-5), 7.49 (2H, dt, J 9:1,
1.6 Hz, H-2, H-6), 7.66 (1H, d, J 16:2 Hz, H-7). 13C-
NMR (100.61 MHz, CDCl3): d 51.61 (q, COOMe),
55.41 (q, OMe), 114.36 (d, C-3, C-5), 115.31 (d, C-8),
127.16 (s, C-1), 129.75 (d, C-2, C-6), 144.56 (d, C-7),
153.74 (s, C-4), 161.43 (s, C-9). EI-MS m/z (rel. int.):
1
Waxy brown solid, a20 20:0 (CHCl3, c 0.2). H-
NMR (400.13 MHz, CDCl3): d 0.82 (3H, d, J 12:6
Hz, H-26), 0.82 (3H, s, H-18), 0.83 (3H, d, J 17:1
Hz, H-27), 0.88 (3H, s, H-19), 0.91 (3H, d, J 6:6 Hz,
H-21), 1.00 (3H, d, J 6:6 Hz, H-28), 3.97 (1H, m, H-
3), 5.14 (1H, dd, J 15:3, 8.2 Hz, H-23), 5.22 (1H, dd,
J 15:2, 7.6 Hz, H-22), 6.24 (1H, d, J 8:7 Hz, H-7),
6.51 (1H, d, J 8:7 Hz, H-6). 13C-NMR (100.61
MHz, CDCl3): see Table 1. EI-MS m/z (rel. int.): 396
[M O2]+ (30), 363 (15), 81 (41), 69 (100).
192 [M]+ (72), 161 [M
OMe]+ (100), 133 [M
COOMe]+ (38), 118 (13), 89 (18).
3.17. Compound 7, quercinic acid B, 24-methylene-3,23-
dioxolanost-8-en-26-oic acid
3.21. Preparation of methyl (E )-4-methoxycinnamate
Waxy yellow solid, a20+37.5] (CHCl3, c 1.0). 1H-
NMR (400.13 MHz, CDCl3): d 0.77 (3H, s, H-18),
0.90 (3H, d, J 8:1 Hz, H-21), 0.91 (3H, s, H-30),
1.07 (3H, s, H-28), 1.10 (3H, s, H-29), 1.13 (3H, s, H-
19), 1.36 (3H, d, J 7:2 Hz, H-27), 5.95 (1H, s, H-
31a), 6.20 (1H, s, H-31b). 13C-NMR (100.61 MHz,
CDCl3): see Table 1. EI-MS m/z (rel. int.): 482 [M]+
Commercially available (E )-4-methoxycinnamic acid
was recrystallized from chloroform and 2 mg were
treated with diazomethane solution until a yellow col-
our remained, indicating an excess of diazomethane.
Finally, the solvent and the diazomethane were
removed in a stream of nitrogen yielding pure methyl
(E )-4-methoxycinnamate.